Boutros
Joseph Boutros, St. Mande FR
Patent application number | Description | Published |
---|---|---|
20100111236 | COURSE TIMING SYNCHRONIZATION - A system for determining the burst start timing of a signal includes logic configured to receive the signal, generate correlation moduli and generate a first timing output based on the correlation moduli. The logic may also be configured to receive operating mode information and timing information and generate search controls. The logic may further be configured to identify a maximum of the correlation moduli using the search controls and determine a second timing output associated with the maximum correlation modulus. The second timing output represents a more accurate approximation of a burst start time than the first timing output. | 05-06-2010 |
20110206172 | COARSE TIME SYNCHRONIZATION - A system for determining the burst start timing of a signal includes logic configured to receive the signal, generate correlation moduli and generate a first timing output based on the correlation moduli. The logic may also be configured to receive operating mode information and timing information and generate search controls. The logic may further be configured to identify a maximum of the correlation moduli using the search controls and determine a second timing output associated with the maximum correlation modulus. The second timing output represents a more accurate approximation of a burst start time than the first timing output. | 08-25-2011 |
Joseph Boutros, Paris FR
Patent application number | Description | Published |
---|---|---|
20130215996 | METHOD AND DEVICE FOR CODED MODULATION - A method for optimising a coded modulation scheme with a given spectral efficiency for communication over a fading channel represented/identified by B fading gains, wherein B is an integer number expressing the ratio between a code word duration and the duration over which the fading remains constant. The fading gains belong to a B-dimensional space of fading gains. | 08-22-2013 |
Matthias Boutros, Neuss DE
Patent application number | Description | Published |
---|---|---|
20080251149 | FUEL PUMP HOUSING - A fuel pump housing includes a body that has a bottom portion. A fuel filter is located adjacent the bottom portion, and contacts the body so that electricity, such as static electricity, is conducted between the body and the fuel filter. A ground connection dissipates, or limits, electricity in both the body and the fuel filter. | 10-16-2008 |
20080310976 | BRUSHLESS MOTOR FUEL PUMP - The invention relates to a fuel conveying device for conveying fuel towards an internal combustion engine. The fuel conveying device comprises a housing and a head connected to the housing. Further, a fuel pump is provided, having an electronically commutated brushless motor. The control electronics for the electronically commutated brushless motor of the fuel pump are carried by or arranged within and/or on the head or housing. | 12-18-2008 |
Michael Boutros, Heidelberg DE
Patent application number | Description | Published |
---|---|---|
20090186815 | IDENTIFICATION OF JAK/STAT PATHWAY MODULATING GENES BY GENOME WIDE RNAI SCREENING - The present invention relates to a method for identifying a compound capable of modulating the activity of the JAK/STAT pathway and to the use of different JAK/STAT pathway components as a target for the modulation of the activity of the JAK/STAT pathway. Moreover, the present invention is concerned with a method for modulating the activity of the JAK/STAT pathway. Furthermore, the present invention pertains to a pharmaceutical composition and to the use of different JAK/STAT pathway components and/or effector molecules thereof for the manufacture of such composition for the diagnosis, prevention or treatment of a JAK/STAT pathway associated disorder. | 07-23-2009 |
20120157481 | TRICYCLIC PYRIMIDINE DERIVATIVES AS WNT ANTAGONISTS - The present invention relates to compounds having the general formula (I) with the definitions of X1-X3, Y1, Y2, L1, R1 and R2 given below and/or solvates, hydrates, esters and pharmaceutically acceptable salts thereof. Furthermore, the invention relates to the use of said compounds for modulating of the Wnt signalling pathway activity and their use as a medicament, preferably for the treatment of cancer. | 06-21-2012 |
20130195884 | NOVEL MODULATORS OF TRAIL SIGNALLING - The present invention relates to an agent for use as a modulator of apoptosis-factor-associated cell death, apoptosis, cell survival, migration and/or proliferation, a method of diagnosing or monitoring apoptosis-factor-associated conditions or disorders as well as a method of identifying a modulator of apoptosis-factor-associated cell death, apoptosis, cell survival, migration and/or proliferation. Preferably, the invention relates to TRAIL-induced cell death and/or TRAIL-induced apoptosis. Preferably the agents are used to stimulate and/or enable TRAIL-induced cell death or to inhibit TRAIL-induced cell death. The preferable use of the diagnostic tools is to diagnose sensitivity or resistance to TRAIL-induced cell death or induction of sensitivity or resistance to TRAIL-induced cell death by an agent. | 08-01-2013 |
20130296344 | CHROMENE DERIVATIVES AND THEIR ANALOGA AS WNT PATHWAY ANTAGONISTS - Compounds according to the general formula (I) wherein X | 11-07-2013 |
20130303550 | CHROMENE DERIVATIVES AND THEIR ANALOGA AS WNT PATHWAY ANTAGONISTS - Compounds of formula (IIc); wherein X | 11-14-2013 |
20140045897 | USE OF BUBR1 AS A BIOMARKER OF DRUG RESPONSE TO FURAZANOBENZIMIDAZOLES - Use of BUBR1 as a biomarker for predicting the response to a compound, preferably resistance of a disease such as cancer in a subject, wherein the compound is a furazanobenzimidazole compound of general formula (I). | 02-13-2014 |
Paul C. Boutros, Toronto CA
Patent application number | Description | Published |
---|---|---|
20120004116 | METHODS FOR BIOMARKER IDENTIFICATION AND BIOMARKER FOR NON-SMALL CELL LUNG CANCER - There is provided a method for identifying a biomarker, such as a gene signature, associated with a biological parameter A 6-gene signature for non-small cell lung cancer (NSCLC) is also provided, as well as a method of prognosing or classifying a subject with non-small cell lung cancer into a poor survival group or a good survival group, using said gene signature | 01-05-2012 |
Sami Boutros, Kanata CA
Patent application number | Description | Published |
---|---|---|
20140211629 | SYSTEM AND METHOD FOR REPORTING OUT-OF-RESOURCES (OOR) CONDITIONS IN A DATA NETWORK - A system and method for advertising out-of-resources (OOR) conditions for entities, such as nodes, line cards and data links, in a manner that does not involve using a maximum cost to indicate the entity is “out-of-resources.” According to the technique, an OOR condition for an entity is advertised in one or more type-length-value (TLV) objects contained in an advertisement message. The advertisement message is flooded to nodes on a data network to inform them of the entity's OOR condition. Head-end nodes that process the advertisement message may use information contained in the TLV object to determine a path for a new label switched path (LSP) that does not include the entity associated with the OOR condition. | 07-31-2014 |